当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析

凯赛生物

(688065)

  

流通市值:285.86亿  总市值:353.43亿
流通股本:5.83亿   总股本:7.21亿

凯赛生物(688065)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.64亿元,每股收益0.23元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2148524.79万元,未分配利润274401.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2455720.27万元,负债307195.49万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入874,529,796.393,295,051,930.282,545,040,722.51,670,767,942.21
营业总成本715,775,081.822,575,128,035.091,946,642,190.871,283,596,878.98
其他经营收益
营业利润192,442,645.42633,753,128.53506,943,908.68345,764,406.94
利润总额192,058,529.59630,164,828.94503,419,479.27342,112,439.58
净利润164,373,725.34529,502,308.11422,904,719.22284,191,771.38
每股收益
其他综合收益159,103.824,771,479.524,490,569.414,035,669.85
综合收益总额164,532,829.16534,273,787.63427,395,288.63288,227,441.23
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计12,266,514,393.4711,731,393,445.3811,491,267,292.3612,011,651,589.28
非流动资产:
非流动资产合计12,290,688,331.9312,150,889,527.6811,953,840,606.3511,809,531,078.47
资产总计24,557,202,725.423,882,282,973.0623,445,107,898.7123,821,182,667.75
流动负债:
流动负债合计2,401,678,420.942,006,499,070.141,655,968,953.741,876,141,935.87
非流动负债:
非流动负债合计670,276,453.3560,939,979.53572,202,742.26870,251,506.82
负债合计3,071,954,874.242,567,439,049.672,228,171,6962,746,393,442.69
所有者权益(或股东权益):
归属于母公司股东权益合计17,871,373,306.4617,699,754,365.7417,597,943,048.9117,452,567,422.38
股东权益合计21,485,247,851.1621,314,843,923.3921,216,936,202.7121,074,789,225.06
负债和股东权益合计24,557,202,725.423,882,282,973.0623,445,107,898.7123,821,182,667.75
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计676,365,167.43,638,405,522.552,602,327,524.21,812,430,577.73
经营活动现金流出小计697,359,781.313,234,282,424.872,329,234,301.961,473,116,722.4
经营活动产生的现金流量净额-20,994,613.91404,123,097.68273,093,222.24339,313,855.32
投资活动产生的现金流量:
投资活动现金流入小计5,712,0003,552,378,756.172,343,262,658.28410,102,862.31
投资活动现金流出小计391,973,342.394,278,261,289.613,786,164,041.341,883,735,109.6
投资活动产生的现金流量净额-386,261,342.39-725,882,533.44-1,442,901,383.06-1,473,632,247.29
筹资活动产生的现金流量:
筹资活动现金流入小计635,537,745.096,754,988,461.136,482,952,613.246,458,513,203.02
筹资活动现金流出小计13,484,968.762,439,799,138.732,410,831,730.531,822,280,245.26
筹资活动产生的现金流量净额622,052,776.334,315,189,322.44,072,120,882.714,636,232,957.76
汇率变动对现金及现金等价物的影响-58,707,879.13-58,919,577.52-25,487,758.21-4,105,233.67
现金及现金等价物净增加额156,088,940.93,934,510,309.122,876,824,963.683,497,809,332.12
期末现金及现金等价物余额9,276,563,963.149,120,475,022.248,062,789,676.88,683,774,045.24
补充资料:
现金及现金等价物的净增加额-3,934,510,309.12-3,497,809,332.12
最新报告期:2026-05-04
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
申万宏源周超,宋涛0.981.151.402026-05-04
华泰证券张雄,庄汀洲,杨文韬1.181.311.412026-04-29
华泰证券张雄,庄汀洲,杨文韬1.181.311.412026-04-24
TOP↑